about
Belimumab in systemic lupus erythematosusJanus kinase inhibitors in autoimmune diseasesThe Role of IL-37 in Non-Cancerous Diseases.Cytokine profile in childhood-onset systemic lupus erythematosus: a cross-sectional and longitudinal study.Activation-induced necroptosis contributes to B-cell lymphopenia in active systemic lupus erythematosus.Central pathways causing fatigue in neuro-inflammatory and autoimmune illnesses.Serum progranulin levels are elevated in dermatomyositis patients with acute interstitial lung disease, predicting prognosisGeographical, environmental and pathophysiological influences on the human blood transcriptome.Pathogenesis and potential therapeutic targets in systemic lupus erythematosus: from bench to bedsideBAFF (B cell activating factor) transcript level in peripheral blood of patients with SLE is associated with same-day disease activity as well as global activity over the next year.Cause-effect relations between 55 kD soluble TNF receptor concentrations and specific and unspecific symptoms in a patient with mild SLE disease activity: an exploratory time series analysis study.Elevated Salivary Alpha-Amylase Level, Association Between Depression and Disease Activity, and Stress as a Predictor of Disease Flare in Systemic Lupus Erythematosus: A Prospective Case-Control Study.Serum Cyr61 is associated with clinical disease activity and inflammation in patients with systemic lupus erythematosus.Metabolic regulation of organelle homeostasis in lupus T cellsRNA-seq Analysis Reveals Unique Transcriptome Signatures in Systemic Lupus Erythematosus Patients with Distinct Autoantibody SpecificitiesNonbilayer Phospholipid Arrangements Are Toll-Like Receptor-2/6 and TLR-4 Agonists and Trigger Inflammation in a Mouse Model Resembling Human Lupus.Human embryonic stem cell-derived mesenchymal cells preserve kidney function and extend lifespan in NZB/W F1 mouse model of lupus nephritisAltered AKT1 and MAPK1 gene expression on peripheral blood mononuclear cells and correlation with T-helper-transcription factors in systemic lupus erythematosus patientsInhibition of SHP2 ameliorates the pathogenesis of systemic lupus erythematosus.Hypergammaglobulinemia in the pediatric population as a marker for underlying autoimmune disease: a retrospective cohort study.Increased risk of systemic lupus erythematosus in pregnancy-induced hypertension: A nationwide population-based retrospective cohort study.Concentrated fish oil (Lovaza(R)) extends lifespan and attenuates kidney disease in lupus-prone short-lived (NZBxNZW)F1 mice.IL-37 inhibits the production of inflammatory cytokines in peripheral blood mononuclear cells of patients with systemic lupus erythematosus: its correlation with disease activity.Future prospects in biologic therapy for systemic lupus erythematosus.Role of renal transporters and novel regulatory interactions in the TAL that control blood pressure.Elevated plasma interleukin-37 levels in systemic lupus erythematosus patients.Radical improvement of signs and symptoms in systemic lupus erythematosus when treated with hemodiafiltration with endogenous reinfusion dialysis.Elevated plasma midkine and pleiotrophin levels in patients with systemic lupus erythematosusHuman Endogenous Retroviral Genetic Element With Immunosuppressive Activity in Both Human Autoimmune Diseases and Experimental Arthritis.Phage display-derived human antibodies in clinical development and therapySubgingival microbiota dysbiosis in systemic lupus erythematosus: association with periodontal status.Increased frequency of a unique spleen tyrosine kinase bright memory B cell population in systemic lupus erythematosus.Challenges in understanding Sjögren's syndrome--improved insights into the pathogenesis generate hope for innovative therapies?Systemic lupus erythematosus: immunopathogenesis and novel therapeutic targets.Serum IP-10 is useful for identifying renal and overall disease activity in pediatric systemic lupus erythematosus.Differential microRNA profile and post-transcriptional regulation exist in systemic lupus erythematosus patients with distinct autoantibody specificities.Gene polymorphism and HLA-G expression in patients with childhood-onset systemic lupus erythematosus: A pilot study.The Cutaneous Spectrum of Lupus Erythematosus.The model of circulating immune complexes and interleukin-6 improves the prediction of disease activity in systemic lupus erythematosus.APRIL levels strongly correlate with IL-17 in systemic lupus erythematosus.
P2860
Q26778277-40056F96-93FE-4322-8956-F79F3F467ECEQ26865446-3979FD95-FDAE-4907-8030-1255C0BDC2A7Q30152709-0F016A1D-9E9C-4F56-861E-924434DE499AQ33653385-1DB05BFE-C14A-40F7-BB17-C2E46EEFD84DQ34476578-D7F50227-A09B-45F6-9158-9EA25B7DAE28Q35059951-AB4C0759-D04D-4C1D-949E-8D4A8358D548Q35163334-23A1DB61-1BD0-4096-B17C-E94EA8B00B4AQ35226568-22F0011C-F05A-4364-BF48-A373CF82B5D6Q35309470-E51788CE-E0C4-44C4-8B7C-A0858F18A2F6Q35768902-3E8B8E6F-7E13-461B-9FA5-3A18A0F69E89Q35782408-361D5D29-CC14-431C-94F7-4226E4D352FFQ36009350-E130AEF8-55BE-4002-9938-758A5A3D8544Q36151613-180D6695-5FF0-4456-B06B-1BB35719686CQ36177195-61989F3B-7E32-47F3-AF7A-2CDB541430F3Q36190001-C32A6116-FB0A-4C8B-A49F-D6DC62727E12Q36237416-C0D89757-16EA-4C57-A331-13A1AFAE90FAQ36340132-EC947E6C-225D-4945-AE7E-3CB44AC3BAC2Q36355671-D3CB682D-6956-491B-B104-79E231FD8CEAQ36951816-6E0D5707-196B-4434-91F7-F4591FED875EQ37317546-C55D36D4-1B28-4F83-8CAB-BFDEF05A1B55Q37605722-C6B9570B-BCD5-4DB0-BB66-732D61420E67Q37673404-2C09430B-79C4-4CAB-BD86-EB491DC513B4Q37730845-920351DD-1282-410D-AD6D-E17203CAA36AQ38135706-A87E3C8B-2973-426E-83E6-6FC399D2CBE6Q39227671-9CB7A3B3-DD5F-4E3B-970C-6413599FA059Q39813149-CC702599-76BB-4202-A4F5-0EA37BC0E5C0Q40153382-43B87946-A8D4-4FA9-B346-B7A017420911Q40448050-18AF828B-149E-4D12-81D6-D81F7F9239C4Q40491107-DE280B6A-94BD-443B-A547-47C9294408EAQ41416393-AA061ACB-C48F-42AD-B5EA-B0223A20F4AEQ42314967-7341F824-F110-4953-9A75-AC1C3501607CQ42464517-83C9CD5D-CF41-45E4-91D2-9CC62D11A8ECQ43013739-93782542-AD10-4516-A638-48596390F2B1Q43988095-A59DAAFF-4ED3-4CE4-ABC8-D46B29208728Q47267579-77BCEBD8-D120-4FC6-A4A6-49B1D96615F4Q47603082-2B1671B3-E797-40AA-BD15-6D28EA52E62DQ48146977-0B262346-466B-4F9B-9548-13B0C49B3E00Q48332079-5DE983FC-FB5C-4188-99D6-9FEAAC813B1DQ49615457-8FDEA5E6-557E-471A-B18C-9D47FFE03B9EQ51125351-F05A4907-7EB5-43BC-9757-2D47654ED59F
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Cytokine disturbances in systemic lupus erythematosus.
@ast
Cytokine disturbances in systemic lupus erythematosus.
@en
type
label
Cytokine disturbances in systemic lupus erythematosus.
@ast
Cytokine disturbances in systemic lupus erythematosus.
@en
prefLabel
Cytokine disturbances in systemic lupus erythematosus.
@ast
Cytokine disturbances in systemic lupus erythematosus.
@en
P2860
P921
P356
P1476
Cytokine disturbances in systemic lupus erythematosus.
@en
P2093
Noam Jacob
William Stohl
P2860
P2888
P356
10.1186/AR3349
P577
2011-07-06T00:00:00Z
P5875
P6179
1041818062